Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
31.74
-0.28 (-0.87%)
At close: Dec 5, 2025, 4:00 PM EST
32.40
+0.66 (2.08%)
After-hours: Dec 5, 2025, 7:27 PM EST
Genmab Market Cap
Genmab has a market cap or net worth of $19.50 billion as of December 5, 2025. Its market cap has increased by 42.53% in one year.
Market Cap
19.50B
Enterprise Value
16.25B
1-Year Change
42.53%
Ranking
Category
Stock Price
$31.74
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $19.50B, an increase of 4,536.37%. That is a compound annual growth rate of 32.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 20.56B | 48.86% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |